3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid)

C95H94F12N26O20 — CID 162132133

IUPAC3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccc(C#N)cc3)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccc(OC)cc3)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccccc3OC)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccccc3[N+](=O)[O-])c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C22H21N7O2.2C22H24N6O3.C21H21N7O4.4C2HF3O2/c1-2-3-10-28-20-18(26-22(28)27-11-8-24-9-12-27)14-25-29(21(20)31)15-19(30)17-6-4-16(13-23)5-7-17;1-3-4-11-27-20-18(25-22(27)26-12-9-23-10-13-26)14-24-28(21(20)30)15-19(29)16-5-7-17(31-2)8-6-16;1-3-4-11-27-20-17(25-22(27)26-12-9-23-10-13-26)14-24-28(21(20)30)15-18(29)16-7-5-6-8-19(16)31-2;1-2-3-10-26-19-16(24-21(26)25-11-8-22-9-12-25)13-23-27(20(19)30)14-18(29)15-6-4-5-7-17(15)28(31)32;4*3-2(4,5)1(6)7/h4-7,14,24H,8-12,15H2,1H3;2*5-8,14,23H,9-13,15H2,1-2H3;4-7,13,22H,8-12,14H2,1H3;4*(H,6,7)
InChIKeyZQRYUJZZGLWSIV-UHFFFAOYSA-N
MW2147.93 g/mol
LogP5.97
Rot. Bonds23

About 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid)

3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid) (PubChem CID 162132133) has the molecular formula C95H94F12N26O20 and a molecular weight of 2147.93 g/mol. Its IUPAC name is 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Name3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid)
PubChem CID162132133
Molecular FormulaC95H94F12N26O20
Molecular Weight2147.93 g/mol
Exact Mass2146.69
IUPAC Name3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccc(C#N)cc3)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccc(OC)cc3)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccccc3OC)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccccc3[N+](=O)[O-])c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C22H21N7O2.2C22H24N6O3.C21H21N7O4.4C2HF3O2/c1-2-3-10-28-20-18(26-22(28)27-11-8-24-9-12-27)14-25-29(21(20)31)15-19(30)17-6-4-16(13-23)5-7-17;1-3-4-11-27-20-18(25-22(27)26-12-9-23-10-13-26)14-24-28(21(20)30)15-19(29)16-5-7-17(31-2)8-6-16;1-3-4-11-27-20-17(25-22(27)26-12-9-23-10-13-26)14-24-28(21(20)30)15-18(29)16-7-5-6-8-19(16)31-2;1-2-3-10-26-19-16(24-21(26)25-11-8-22-9-12-25)13-23-27(20(19)30)14-18(29)15-6-4-5-7-17(15)28(31)32;4*3-2(4,5)1(6)7/h4-7,14,24H,8-12,15H2,1H3;2*5-8,14,23H,9-13,15H2,1-2H3;4-7,13,22H,8-12,14H2,1H3;4*(H,6,7)
InChIKeyZQRYUJZZGLWSIV-UHFFFAOYSA-N
XLogP5.97
TPSA574.79 Ų
H-Bond Donors8
H-Bond Acceptors41
Rotatable Bonds23
Heavy Atoms153
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002147.93
LogP ≤ 55.97
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1041

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid)?
The IUPAC name of 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid) (CID 162132133) is 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid) is CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccc(C#N)cc3)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccc(OC)cc3)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccccc3OC)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(CC(=O)c3ccccc3[N+](=O)[O-])c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.
What is the InChIKey of 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid)?
The InChIKey is ZQRYUJZZGLWSIV-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H21N7O2.2C22H24N6O3.C21H21N7O4.4C2HF3O2/c1-2-3-10-28-20-18(26-22(28)27-11-8-24-9-12-27)14-25-29(21(20)31)15-19(30)17-6-4-16(13-23)5-7-17;1-3-4-11-27-20-18(25-22(27)26-12-9-23-10-13-26)14-24-28(21(20)30)15-19(29)16-5-7-17(31-2)8-6-16;1-3-4-11-27-20-17(25-22(27)26-12-9-23-10-13-26)14-24-28(21(20)30)15-18(29)16-7-5-6-8-19(16)31-2;1-2-3-10-26-19-16(24-21(26)25-11-8-22-9-12-25)13-23-27(20(19)30)14-18(29)15-6-4-5-7-17(15)28(31)32;4*3-2(4,5)1(6)7/h4-7,14,24H,8-12,15H2,1H3;2*5-8,14,23H,9-13,15H2,1-2H3;4-7,13,22H,8-12,14H2,1H3;4*(H,6,7).
What are the key properties of 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid)?
3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid) has a molecular weight of 2147.93 g/mol, XLogP of 5.97, 23 rotatable bonds, 8 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for 3-but-2-ynyl-5-[2-(2-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(4-methoxyphenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;3-but-2-ynyl-5-[2-(2-nitrophenyl)-2-oxoethyl]-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[2-(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)acetyl]benzonitrile;tetrakis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 162132133), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).